Cell Source, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Cell Source, Inc. (CLCS) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $717.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-01.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2019-04-01
- Cell Source, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2018 was $717.00K, a 75.74% increase from fiscal 2017.
- Cell Source, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2017 was $408.00K, a 65.57% decline from fiscal 2016.
- Cell Source, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2016 was $1.19M, a 83.44% increase from fiscal 2015.
- Cell Source, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2015 was $646.00K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2018-12-31 | $717.00K 10-K · filed 2019-04-01 | |
| 2017-12-31 | $408.00K 10-K · filed 2019-04-01 | |
| 2016-12-31 | $1.19M 10-K · filed 2018-07-25 | |
| 2015-12-31 | $646.00K 10-K · filed 2018-07-25 | -$646.00K 10-K · filed 2016-04-14 |
| 2014-12-31 | -$1.15M 10-K · filed 2016-04-14 |